This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Akio Inui, MD, PhD; Masaharu Uemoto, MD, PhD; Shizuo Takamiya, MD; Yuhei Shibuya, MD, PhD; Shigeaki Baba, MD, PhD; Masato Kasuga, MD, PhD
Kobe, Japan

Arch Intern Med. 1997;157(4):464.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Prader-Willi syndrome is a disorder characterized by obesity, hypogonadism, hypotonia, and mental retardation, which is genetically caused by a deletion of a small part of chromosome 15 in some, but not all, patients.^1-4 Obesity is associated with diabetes mellitus of the maturity-onset type. The hyperphagia associated with Prader-Willi syndrome is severe and chronic and is responsible for the early mortality of people with the condition. The hyperphagia, together with the behavioral difficulties, makes Prader-Willi syndrome one of the most serious and pervasive conditions with respect to its impact on the family unit.

Report of a Case.

We treated a male patient with Prader-Willi syndrome and overt diabetes mellitus for which he took insulin; we found that the addition of a small dose of mazindol to the insulin therapy was effective in preventing hyperglycemic coma. At the time of the initial mazindol administration, the patient was 23 years old and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?